Dr. Roshawnna Novellus raised over $600,000 to fund her college education. For most people, it’s hard enough finding money to pay for one college degree. But Dr. Novellus used her crowdfunding ...

NEW YORK (CNN/Money) - Novellus Systems Tuesday raised its earnings target for the second quarter and said orders for its chip-making equipment have been stronger than expected. At the same time ...

NEW YORK (CNNmoney) - Novellus Systems Monday logged a third-quarter operating profit that matched Wall Street's expectations on stronger-than-expected sales. After the closing bell, Novellus ...

Entrepreneur Roshawnna Novellus was finally able to refinance her home after an acquaintance recommended she go to a more diverse brokerage. Personal Finance 2021-12-05T12:30:00Z ...

LOS ANGELES (MarketWatch) -- Novellus Systems Inc. on Tuesday reported second-quarter profit sank 12% on a slight decline in sales, and the maker of semiconductor-manufacturing equipment said ...

Lam Research Corp. agreed to buy Novellus Systems Inc. for about $3.3 billion in stock, combining two of the chip-equipment industry’s biggest companies in a challenge to market leader Applied ...

Novellus Systems Inc. will cut its global work force 10% by the end of January and slash its chief executive's salary in half as the maker of semiconductor-manufacturing tools expands its ...

BERKELEY, Calif. & JERUSALEM--(BUSINESS WIRE)--Novellus, a precision-oncology drug development company, announced today that it has entered into an exclusive worldwide license agreement with ...

SAN JOSE, Calif. -- Novellus Systems Inc.'s first-quarter net income more than tripled amid a 41% jump in sales despite continued weak demand for semiconductor equipment. The chip-equipment maker ...

SAN FRANCISCO (CBS.MW) -- Computer chip-equipment maker Novellus Corp. said in a filing with securities regulators Friday that it and rival Applied Materials have agreed to dismiss all pending ...

Cancer biotech Novellus has struck a deal with Plexxikon for its early- to midstage BRAF-inhibiting hopeful PLX8394. Little-known Novellus is licensing the drug, currently in phase 1/2 tests with ...